[1]
M. S. Rohman, “In Silico Discovery of Green Tea and Green Coffee Bioactive Compounds Against IGF-1R, PPAR-α, and TLR4 as a Therapeutic Candidate for Metabolic Disorder”, TJNPR, vol. 8, no. 3, pp. 6594–6603, Mar. 2024, doi: 10.26538/tjnpr/v8i3.18.